CT
Contineum Therapeutics, Inc. (CTNM)
NASDAQ·Healthcare·Biotechnology
$9.52
+8.29%
Mkt Cap $336.56M
Analyst Ratings
Buy
4
Hold
3
Sell
0
Price Target (12 analysts)
$21.33
Range $17.00 – $28.00
Implied Upside
+124.1%
Consensus $21.33 vs current $9.52
NASDAQ·Healthcare·Biotechnology
$9.52
+8.29%
Mkt Cap $336.56M
Buy
4
Hold
3
Sell
0
Price Target (12 analysts)
$21.33
Range $17.00 – $28.00
+124.1%
Consensus $21.33 vs current $9.52